Related Experiment Video

Updated: Mar 21, 2026

Biochemical Measurement of Neonatal Hypoxia
13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

14.5K

New approaches to management of neonatal hypoglycemia

Paul J Rozance1, William W Hay1

  • 1Perinatal Research Center, Department of Pediatrics, University of Colorado School of Medicine, 13243 E 23rd Ave, MS F441, Aurora, CO 80045 USA.

Maternal Health, Neonatology and Perinatology
|May 12, 2016
PubMed

Insights

New research offers insights into managing neonatal hypoglycemia. Buccal dextrose gel shows promise for asymptomatic cases, and glycemic patterns are linked to two-year neurodevelopmental outcomes in high-risk infants.

Area of Science:

  • Neonatal Medicine
  • Endocrinology
  • Developmental Pediatrics

Background:

  • Management of low glucose concentrations in newborns (neonatal hypoglycemia) within the first 48 hours of life lacks established consensus.
  • Limited primary data has hindered the development of a universally agreed-upon approach.
  • Recent studies provide crucial data, focusing on high-risk infant populations.

Purpose of the Study:

  • To review new research on managing asymptomatic neonatal hypoglycemia.
  • To discuss the efficacy of buccal dextrose gel for neonatal hypoglycemia.
  • To explore the relationship between glycemic patterns and neurodevelopmental outcomes in infants.

Main Methods:

  • Review of recent publications on neonatal glucose management.
  • Focus on studies involving high-risk neonates: late-preterm, large/small for gestational age, growth-restricted, and infants of diabetic mothers.
  • Analysis of data from a prospective study linking glycemic patterns to neurodevelopment.

Main Results:

  • Promising new data suggests buccal dextrose gel as a potential treatment for asymptomatic neonatal hypoglycemia.
  • A large prospective study identified associations between specific glycemic patterns and neurodevelopmental outcomes at two years of age.

Conclusions:

  • Buccal dextrose gel warrants further investigation for managing neonatal hypoglycemia.
  • Understanding glycemic patterns in high-risk newborns is crucial for predicting long-term neurodevelopmental outcomes.

Keywords:
Continuous glucose monitoringDextrose gelInfant of a diabetic motherIntrauterine growth restrictionLarge for gestational ageLate pretermNeonatal hypoglycemiaSmall for gestational age

More Related Videos

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs08:58

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs

Published on: October 31, 2025

802
A Piglet Model of Neonatal Hypoxic-Ischemic Encephalopathy10:30

A Piglet Model of Neonatal Hypoxic-Ischemic Encephalopathy

Published on: May 16, 2015

20.3K

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.2K
SBAR II: Application of SBAR01:14

SBAR II: Application of SBAR

SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
6.8K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.4K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.4K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.9K